Fulgent Genetics (FLGT) Total Non-Current Liabilities (2016 - 2026)

Fulgent Genetics has disclosed Total Non-Current Liabilities across 11 years of filings, most recently posting $84.3 million for Q2 2026.

• In Q2 2026, Total Non-Current Liabilities rose 2.39% year-over-year to $84.3 million; the TTM figure through Jun 2026 stood at $84.3 million (up 2.39% YoY), while the FY2025 annual figure was $99.2 million, up 18.32% from the prior year.
• Total Non-Current Liabilities came in at $84.3 million for Q2 2026 at Fulgent Genetics, down from $102.8 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $142.9 million in Q1 2022 to a low of $74.7 million in Q2 2023.
• Average Total Non-Current Liabilities over 5 years is $93.9 million, with a median of $88.0 million recorded in 2024.
• Year-over-year, Total Non-Current Liabilities plunged 42.24% in 2023 and jumped 33.82% in 2026.
• Over 5 years, Total Non-Current Liabilities stood at $97.9 million in 2022, then fell by 11.22% to $87.0 million in 2023, then decreased by 3.59% to $83.8 million in 2024, then gained by 18.32% to $99.2 million in 2025, then declined by 15.04% to $84.3 million in 2026.
• Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $84.3 million in Q2 2026, $102.8 million in Q1 2026, and $99.2 million in Q4 2025.